Work

Results of a phase II multicenter study of obinutuzumab plus bendamustine in pts with previously untreated chronic lymphocytic leukemia (CLL).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.7523

Authors: Jeff Porter Sharman, Habte Aragaw Yimer, Michael Boxer, Nicholas DiBella, Sunil Babu, Jia Li, Yong Jun Mun, Sandra L. Skettino, Alexey Valeryevich Danilov

Institutions: Willamette Valley Cancer Institute and Research Center, Texas Oncology, Arizona Oncology, Rocky Mountain Cancer Centers, Genentech, Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890048426

Cites:

Cited by: 5

Related to: 10